Segment Information (Tables)

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Summary of Net sales and Operating Profit by Segment

Net sales and operating profit by segment are as follows (in millions):

	Net Sales				Operating Profit
	Three Months Ended				Three Months Ended
	June 30,				June 30,
	2019		2018		2019			2018
Americas	$	989.1	$	979.3	$	538.8		$	530.1
EMEA		383.2		400.0		116.9			117.5
Asia Pacific		321.9		319.2		114.8			109.7
Product Category Operating Segments		294.4		309.1		49.7			39.4
Global Operations and Corporate Functions		-		-		(275.0	)		(235.2	)
Total	$	1,988.6	$	2,007.6
Inventory and manufacturing-related charges						(34.1	)		(12.5	)
Intangible asset amortization						(146.9	)		(149.5	)
Intangible asset impairment						(70.1	)		-
Acquisition, integration and related						(10.5	)		(50.5	)
Quality remediation						(23.4	)		(45.4	)
Litigation						(7.0	)		4.2
European Union Medical Device Regulation						(5.1	)		(0.5	)
Other charges						(43.4	)		(11.3	)
Operating profit					$	204.7		$	296.0

	Net Sales				Operating Profit
	Six Months Ended				Six Months Ended
	June 30,				June 30,
	2019		2018		2019			2018
Americas	$	1,964.5	$	1,970.4	$	1,045.9		$	1,062.3
EMEA		789.1		832.6		243.3			256.7
Asia Pacific		625.6		618.1		218.8			211.8
Product Category Operating Segments		584.9		604.1		90.6			92.6
Global Operations and Corporate Functions		-		-		(528.4	)		(490.1	)
Total	$	3,964.1	$	4,025.2
Inventory and manufacturing-related charges						(36.1	)		(19.7	)
Intangible asset amortization						(290.3	)		(300.3	)
Intangible asset impairment						(70.1	)		-
Acquisition, integration and related						(21.2	)		(96.5	)
Quality remediation						(43.1	)		(91.6	)
Litigation						(5.2	)		(1.5	)
Litigation settlement gain						23.5			-
European Union Medical Device Regulation						(6.7	)		(0.8	)
Other charges						(66.1	)		(21.9	)
Operating profit					$	554.9		$	601.0